Loading...
Zydus Lifesciences Limited — Budesonide Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #3 for Budesonide · $2.4M export value · DGFT Verified
Zydus Lifesciences Limited is the #3 Indian exporter of Budesonide with $2.4M in export value and 78 verified shipments. Zydus Lifesciences Limited holds a 1.3% market share in Budesonide exports across 7 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $521.7K | 31 | 33.4% |
| UNITED STATES OF AMERICA | $350.0K | 7 | 22.4% |
| SRI LANKA | $300.0K | 18 | 19.2% |
| VIETNAM, DEMOCRATIC REP. OF | $255.7K | 8 | 16.3% |
| UGANDA | $79.0K | 6 | 5.1% |
| VIETNAM | $22.4K | 1 | 1.4% |
| MAURITIUS | $19.1K | 5 | 1.2% |
| VIETNAM DEMOCRATIC REP. OF | $15.3K | 1 | 1.0% |
| MYANMAR | $865 | 1 | 0.1% |
Zydus Lifesciences Limited exports Budesonide to 9 countries. The largest destination is KENYA accounting for 33.4% of Zydus Lifesciences Limited's Budesonide shipments, followed by UNITED STATES OF AMERICA (22.4%) and SRI LANKA (19.2%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ABACUS PHARMA (AFRICA) LTD | UGANDA | $341.0K | 20 |
| SUNSHINE HEALTHCARE LANKA LIMITED | SRI LANKA | $291.5K | 17 |
| HAPHARCO J.S.C. BRANCH | VIETNAM, DEMOCRATIC REP. OF | $271.0K | 9 |
| XXRTHXXAR XXALTXXAREXXNLIXXTEDXXOMPX | UNITED STATES OF AMERICA | $200.0K | 4 |
| XXDUSXXHARXXCEUXXCALXXUSAXXNC | UNITED STATES OF AMERICA | $150.0K | 3 |
| ABACUS PHARMA AFRICA LTD | KENYA | $94.5K |
India exported $70.6M worth of Budesonide through 9,145 shipments from 275 suppliers to 115 countries, serving 609 buyers globally. Zydus Lifesciences Limited contributes $2.4M to this total, accounting for 1.3% of India's Budesonide exports. Zydus Lifesciences Limited ships Budesonide to 9 countries through 15 buyers.
Zydus Lifesciences Limited's average Budesonide shipment value is $30.9K per consignment, based on 78 shipments totaling $2.4M. The largest destination is KENYA (33.4% of Zydus Lifesciences Limited's Budesonide exports).
Zydus Lifesciences Limited ranks #3 among 275 Indian Budesonide exporters with a 1.3% market share. The top 3 exporters are CIPLA LIMITED ($53.0M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($7.8M), ZYDUS LIFESCIENCES LIMITED ($2.4M). Zydus Lifesciences Limited processed 78 shipments to 7 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| BUDESONIDE ENTERIC COATED CAPSULE 3 MG - | $300.0K | 6 |
| FORMONIDE 200 INHALER (BUDESONIDE & FORM | $278.0K | 15 |
| FORMONIDE 400 INHALER (FORMOTEROL FUMARATE AND BUDESONIDE INHALATION 120MD) 1X1 UNIT | $110.0K | 5 |
| FORMONIDE 400 MDI 1'S- HFA(FORMOTEROL FUMARATE & BUDESONIDE INHALATION)(1 X 1 UNIT) | $91.5K | 4 |
| BUDESONIDE ENTERIC COATED CAPSULE 3 MG | $50.0K | 1 |
| FORMONIDE 200 INHALER 120 MDI BUDESONIDE FORMOTEROL FUMARATE INHALER 120 MDI | $50.0K | 1 |
| FORMONIDE 200 INHALER (BUDESONIDE & FORMOTEROL FUMARATE INHALER) 1X120MDI UNDERLUT NO. AD240323012473N DATED 14.03.2023NOS | $47.4K | 2 |
| FORMONIDE 200 INHALER (BUDESONIDE & FORMOTEROL FUMARATE INHALER) 1X120MDI | $43.8K |
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED | $53.0M | 1,060 | 31 | $50.0K |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $7.8M | 166 | 3 | $47.1K |
| 3 | ZYDUS LIFESCIENCES LIMITED ★ | $2.4M | 78 | 7 | $30.9K |
| 4 | AHLCON PARENTERALS (INDIA) LIMITED | $1.1M | 22 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,990 | 21.8% |
| DELHI AIR CARGO ACC (INDEL4) | 1,616 | 17.7% |
| DELHI AIR | 1,404 | 15.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,213 | 13.3% |
| Delhi Air | 419 | 4.6% |
| Bombay Air | 386 | 4.2% |
| NHAVA SHEVA SEA (INNSA1) | 303 | 3.3% |
| Delhi Air Cargo | 152 | 1.7% |
Visual overview of India's budesonide supplier profile for Zydus Lifesciences Limited — top suppliers, destinations, pricing, and trade routes
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Budesonide, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Budesonide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Budesonide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
| 3 |
| GALAXY PHARMACEUTICAL LIMITED | KENYA | $57.3K | 7 |
| RIPPLE PHARMACEUTICALS | KENYA | $39.6K | 3 |
| ABACUS PHARMA (AFRICA) LTD. | UGANDA | $33.5K | 2 |
| HAPHARCO J S C BRANCH | VIETNAM | $22.4K | 1 |
Zydus Lifesciences Limited supplies Budesonide to 15 buyers globally. The largest buyer is ABACUS PHARMA (AFRICA) LTD (UGANDA), followed by SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA) and HAPHARCO J.S.C. BRANCH (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| 1 |
| FORMONIDE 200 INHALER (FORMOTEROL FUMARATE AND BUDESONIDE INHALATION) 1X120MDI | $37.9K | 1 |
| FORMONIDE 200 INHALER (BUDESONIDE & FORMOTEROL FUMARATE INHALER) 120 MDI | $35.9K | 1 |
Zydus Lifesciences Limited exports 43 distinct Budesonide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BUDESONIDE ENTERIC COATED CAPSULE 3 MG - with 6 shipments worth $300.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
| 2 |
| $50.0K |
| 5 | AHLCON PARENTERALS INDIA LIMITED | $1.1M | 22 | 2 | $49.2K |
Zydus Lifesciences Limited ranks #3 among 275 Indian Budesonide exporters. Average shipment value of $30.9K compared to the market average of $256.7K. The closest competitors by value are CIPLA LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 609+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Budesonide. For current shipment-level data, contact TransData Nexus.